Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Consensus guidelines for the detection of immunogenic cell death
Oliver Kepp, Laura Senovilla, Ilio Vitale, et al.
OncoImmunology (2014) Vol. 3, Iss. 9, pp. e955691-e955691
Open Access | Times Cited: 755

Showing 26-50 of 755 citing articles:

Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy
Jonathan Pol, Erika Vacchelli, Fernando Aranda, et al.
OncoImmunology (2015) Vol. 4, Iss. 4, pp. e1008866-e1008866
Open Access | Times Cited: 274
Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy
Marie‐Claude Bourgeois‐Daigneault, Dominic G. Roy, Amelia S. Aitken, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 422
Open Access | Times Cited: 265
The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death
Chiara Pozzi, Alessandro Cuomo, Ilaria Spadoni, et al.
Nature Medicine (2016) Vol. 22, Iss. 6, pp. 624-631
Closed Access | Times Cited: 251
Trial watch
Erika Vacchelli, Alexander Eggermont, Catherine Sautès‐Fridman, et al.
OncoImmunology (2013) Vol. 2, Iss. 6, pp. e24612-e24612
Open Access | Times Cited: 250
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Zong Sheng Guo, Binfeng Lu, Zongbi Guo, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 250
Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics
Abhishek D. Garg, Sanket More, Nicole Rufo, et al.
OncoImmunology (2017) Vol. 6, Iss. 12, pp. e1386829-e1386829
Open Access | Times Cited: 241
NLRP3 inflammasome activation mediates estrogen deficiency-induced depression- and anxiety-like behavior and hippocampal inflammation in mice
Yongjun Xu, Hui Sheng, Qing‐Yue Bao, et al.
Brain Behavior and Immunity (2016) Vol. 56, pp. 175-186
Closed Access | Times Cited: 239
The immune response to secondary necrotic cells
Monika Sachet, Ying Liang, Rudolf Oehler
APOPTOSIS (2017) Vol. 22, Iss. 10, pp. 1189-1204
Open Access | Times Cited: 239
Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy
Xiao Zhao, Keni Yang, Ruifang Zhao, et al.
Biomaterials (2016) Vol. 102, pp. 187-197
Closed Access | Times Cited: 232
Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy
Alfonso R. Sánchez-Paulete, Álvaro Teijeira, Francisco J. Cueto, et al.
Annals of Oncology (2017) Vol. 28, pp. xii44-xii55
Open Access | Times Cited: 231
Immunogenic cell death in anticancer chemotherapy and its impact on clinical studies
Qiang Wang, Xiaoli Ju, Jiayou Wang, et al.
Cancer Letters (2018) Vol. 438, pp. 17-23
Closed Access | Times Cited: 230
Immunogenic cell death
Abhishek D. Garg, Aleksandra M. Dudek-Perić, Erminia Romano, et al.
The International Journal of Developmental Biology (2015) Vol. 59, Iss. 1-2-3, pp. 131-140
Open Access | Times Cited: 222
Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming
María E. Rodríguez-Ruiz, Inmaculada Rodríguez, Saray Garasa, et al.
Cancer Research (2016) Vol. 76, Iss. 20, pp. 5994-6005
Open Access | Times Cited: 217
Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity
Mikako Ogawa, Yusuke Tomita, Yuko Nakamura, et al.
Oncotarget (2017) Vol. 8, Iss. 6, pp. 10425-10436
Open Access | Times Cited: 217
Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway
Jianqin Lu, Xiangsheng Liu, Yu‐Pei Liao, et al.
ACS Nano (2018) Vol. 12, Iss. 11, pp. 11041-11061
Open Access | Times Cited: 215
Combining DNA damaging therapeutics with immunotherapy: more haste, less speed
Jessica Brown, Raghav Sundar, Juanita Lopez
British Journal of Cancer (2017) Vol. 118, Iss. 3, pp. 312-324
Open Access | Times Cited: 214
Non‐Thermal Plasma as a Unique Delivery System of Short‐Lived Reactive Oxygen and Nitrogen Species for Immunogenic Cell Death in Melanoma Cells
Abraham Lin, Yury Gorbanev, Joey De Backer, et al.
Advanced Science (2019) Vol. 6, Iss. 6
Open Access | Times Cited: 213
Photothermal Therapy Generates a Thermal Window of Immunogenic Cell Death in Neuroblastoma
Elizabeth E. Sweeney, Juliana Cano‐Mejia, Rohan Fernandes
Small (2018) Vol. 14, Iss. 20
Closed Access | Times Cited: 210
Oncolytic Viruses and the Immune System: The Dynamic Duo
Ana Lemos de Matos, Lina S. Franco, Grant McFadden
Molecular Therapy — Methods & Clinical Development (2020) Vol. 17, pp. 349-358
Open Access | Times Cited: 205
An ER‐Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non‐Small‐Cell Lung Cancer
Lili Wang, Ruilin Guan, Lina Xie, et al.
Angewandte Chemie International Edition (2020) Vol. 60, Iss. 9, pp. 4657-4665
Closed Access | Times Cited: 205
Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysis
Abhishek D. Garg, Dirk De Ruysscher, Patrizia Agostinis
OncoImmunology (2015) Vol. 5, Iss. 2, pp. e1069938-e1069938
Open Access | Times Cited: 203
Hypoxia-Driven Immune Escape in the Tumor Microenvironment
Alyssa Vito, Nader El-Sayes, Karen L. Mossman
Cells (2020) Vol. 9, Iss. 4, pp. 992-992
Open Access | Times Cited: 203
Intratumoral Delivery of Immunotherapy—Act Locally, Think Globally
M. Angela Aznar, Nicola Tinari, Antonio Rullan, et al.
The Journal of Immunology (2016) Vol. 198, Iss. 1, pp. 31-39
Open Access | Times Cited: 201
Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death
Kazukuni Hayashi, Fotis Nikolos, Y. C. Lee, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 199
Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 195

Scroll to top